Highly contagious and often underestimated, respiratory syncytial virus (RSV) causes about 2.1 million outpatient visits in the United States every year. Fortunately, recent advancements in vaccines and antibody therapies can bolster prevention. Gain an overview of RSV, and learn about risk factors, prevention tools, and the important of raising awareness of RSV.*This course was previously part of the January/February 2025 MA Today course bundle. Please ensure you have not already completed this course prior to purchase.